Envisage report cover

In Situ Hybridization Market - By Product (Consumables, Instruments, Software) By Technology (Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)) By Application (Cancer Diagnostics, Cytology, Infectious Disease Diagnostics, Neuroscience, Immunology) By End User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CROs) By Region (North America, Europe, Asia-Pacific, LAMEA) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 193

Status: Published

Report Code: EMR100776

Global in situ hybridization market is valued USD 0.79 billion in 2020 and expected to reach USD 1.32 billion by 2027, registering a substantial CAGR of 7.6% in the forecast period of 2020-2027. This rise in the market can be attributed to the automation in diagnostic kits and real time for accurate diagnosis of cytogenetic modifications, rise in research and development related to the application of ISH in testing of infectious diseases and increase in number of incidences of cancer.

In situ hybridization is a technique which helps in precisely localization of particular segment of nucleic acid in a histologic section. The DNA or RNA probe is used in detecting complementary genetic material in tissues or cells. In situ hybridization is specifically useful in neuroscience. In situ hybridization has wide applications in microbiology, pathology, developmental biology, karyotyping & phylogenetic analysis and physical mapping.

DNA probe-based diagnostics is gaining popularity in medical diagnostics for the determination of suspected diseases caused by pathogens or bacteria. In addition, identification of new areas for diagnostic markets increased automation of diagnostic tests, and investments in pharmacogenomics and pharmaceutical research are the major factors propelling the growth. Increasing prevalence of genetic disorders such as Acute Lymphoblastic Leukemia (ALL) is further driving the market growth. For Instance, according to the American Cancer Society, almost 7000 new cases of ALL were diagnosed in 2018, with more than 1500 deaths in the U.S.

Rising prevalence of diseases having the cytogenetic base such as genetic abnormalities and cancer coupled with the demand for rapid, sensitive, and accurate prognosis techniques for disease validation is anticipated to boost the adoption of FISH probe techniques and thereby fuel the market growth over the forecast period.

Some of the key market players operating are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Agilent Technologies, Abnova Corporation, BioGenex Laboratories, Bio-Techne Corporation, Biocare Medical, and Bio SB and Others.
Analyst Commentary

The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the ISH market for diagnostics and research applications.

Although RT-PCR is widely used to detect and diagnose coronavirus in human samples, researchers and diagnostics companies across the globe are finding cost-effective and sensitive assay kits to deal with the pandemic. Molecular cytogenetics tests such as ISH play a role in identifying infected cells or tissue. As a result, in 2020, some companies in this market have focused on launching COVID-19 specific probes. A US-based firm, Creative Bioarray (US), launched a 2019 Novel Coronavirus Detection FISH Probe for the detection of viral particles in cells. Bio-Techne (US), is helping researchers with its RNAscope technology that allows the visualization of viral loads in cell and tissues using its V-nCoV2019-S probe.

With its applications in infectious disease diagnostics, the impact of COVID will have a short-term positive effect on the ISH market.

Segmentation

This market segments the global in situ hybridization market based on product, technology, application, end user, and region. Based on Product market is categorized into Consumables, Instruments, Software. Based on Technology, it is categorized into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). Based on Application it is classified into Cancer Diagnosis, Immunology, Neuroscience, Cytology, and Infectious Diseases. Based on End User, it is bifurcated Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS), and Academic & Research Institutions. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Regional Analysis

North America accounted for the largest revenue share in 2018. High incidence rate of genetic disorders leading to birth defects, developmental disabilities, and other metabolic syndromes are some of the factors attributed to the growth. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 3% to 4% of newborns in the U.S. were born with genetic abnormalities. Approximately 10% of adults and 30% of children in the country were hospitalized owing to genetic disorders. Fluorescent ISH is estimated to provide 98% accuracy in the detection of chromosomal aberrations leading to such disorders.

In addition, usage of these assays in various diseases such as cancer and genetic disorders is on the rise in this region and is further expected to drive the demand. Rising awareness among people regarding early diagnosis of genetic disorders, increasing disposable income, and highly established R&D infrastructure are the key factors attributed to the market growth. Favorable healthcare reimbursement policies and government reforms are anticipated to push the industry further.

Asia Pacific is anticipated to showcase lucrative growth in the forthcoming years. The industry is growing in terms of revenue generation from the cytogenetics and molecular diagnostic sectors in this region. The presence of supportive government initiatives pertaining to the increasing investments by manufacturers and government in the biotechnology sector and high untapped opportunities are the important factors propelling the regional growth.

In addition, continuous R&D activities for cancer treatment facilitate the demand for cancer research and are expected to fuel the regional demand in the near future. Growing adoption of new techniques for molecular-based cytogenetics, increasing outsourcing activities, and demand for early diagnosis and detection of diseases are anticipated to propel the regional growth.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On In Situ Hybridization Market
Chapter 5. Global In Situ Hybridization Market Overview, By Product, 2015 – 2027 (USD Billion)
5.1. Global In Situ Hybridization Market Share, By Product, 2020 & 2027 (%)
5.1.1. Consumables
5.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
5.1.2. Instruments
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
5.1.3. Software
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 6. Global In Situ Hybridization Market Overview, By Technology, 2015 – 2027 (USD Billion)
6.1. Global In Situ Hybridization Market Share, By Technology, 2020 & 2027 (%)
6.1.1. FISH
6.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
6.1.2. CISH
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 7. Global In Situ Hybridization Market Overview, By Application, 2015 – 2027 (USD Billion)
7.1. Global In Situ Hybridization Market Share, By Application, 2020 & 2027 (%)
7.1.1. Cancer Diagnostics
7.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.2. Cytology
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.3. Infectious Disease Diagnostics
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.4. Neuroscience
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.5. Immunology
7.1.5.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 8. Global In Situ Hybridization Market Overview, By End User, 2015 – 2027 (USD Billion)
8.1. Global In Situ Hybridization Market Share, By End User, 2020 & 2027 (%)
8.1.1. Hospitals & Diagnostic Laboratories
8.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
8.1.2. Academic & Research Institutes
8.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
8.1.3. Pharmaceutical & Biotechnology Companies
8.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
8.1.4. CROs
8.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 9. Global In Situ Hybridization Market Overview, By Geography, 2015 - 2027 (USD Billion)
9.1. Global In Situ Hybridization Market Share, By Geography, 2015 - 2027(USD Billion)
9.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 (%)
Chapter 10. North America In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. North America In Situ Hybridization Market Overview, 2020 & 2027 (%)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. North America In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.3. North America In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
10.1.4. North America In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5. North America In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
10.1.6. North America In Situ Hybridization Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.6.1. U.S. In Situ Hybridization Market Overview, 2015 - 2027 (USD Billion)
10.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.1.2. U.S. In Situ Hybridization Market Overview, By Product, 2015 - 2027 (USD Billion)
10.1.6.1.3. U.S. In Situ Hybridization Market Overview, By Technology, 2015 - 2027 (USD Billion)
10.1.6.1.4. U.S. In Situ Hybridization Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.6.1.5. U.S. In Situ Hybridization Market Overview, By End User, 2015 - 2027 (USD Billion)
10.1.6.2. Canada In Situ Hybridization Market Overview, 2015 - 2027 (USD Billion)
10.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.2.2. Canada In Situ Hybridization Market Overview, By Product, 2015 - 2027 (USD Billion)
10.1.6.2.3. Canada In Situ Hybridization Market Overview, By Technology, 2015 - 2027 (USD Billion)
10.1.6.2.4. Canada In Situ Hybridization Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.6.2.5. Canada In Situ Hybridization Market Overview, By End User, 2015 - 2027 (USD Billion)
10.1.6.3. Mexico In Situ Hybridization Market Overview, 2015 - 2027 (USD Billion)
10.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.3.2. Mexico In Situ Hybridization Market Overview, By Product, 2015 - 2027 (USD Billion)
10.1.6.3.3. Mexico In Situ Hybridization Market Overview, By Technology, 2015 - 2027 (USD Billion)
10.1.6.3.4. Mexico In Situ Hybridization Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.6.3.5. Mexico In Situ Hybridization Market Overview, By End User, 2015 - 2027 (USD Billion)
Chapter 11. Europe In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
11.1. Europe In Situ Hybridization Market Overview, 2020 & 2027 (%)
11.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.2. Europe In Situ Hybridization Market Overview, By Product, 2015 - 2027 (USD Billion)
11.1.3. Europe In Situ Hybridization Market Overview, By Technology, 2015 - 2027 (USD Billion)
11.1.4. Europe In Situ Hybridization Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5. Europe In Situ Hybridization Market Overview, By End User, 2015 - 2027 (USD Billion)
11.1.6. Europe In Situ Hybridization Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.6.1. Germany
11.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.1.2. Germany In Situ Hybridization Market Overview, By Product, 2015 - 2027 (USD Billion)
11.1.6.1.3. Germany In Situ Hybridization Market Overview, By Technology, 2015 - 2027 (USD Billion)
11.1.6.1.4. Germany In Situ Hybridization Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.6.1.5. Germany In Situ Hybridization Market Overview, By End User, 2015 - 2027 (USD Billion)
11.1.6.1.6. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.1.7. France In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.6.1.8. France In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
11.1.6.1.9. France In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.6.1.10. France In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.6.2. UK
11.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.2.2. UK In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.6.2.3. UK In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
11.1.6.2.4. UK In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.6.2.5. UK In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.6.3. Italy
11.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.3.2. Italy In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.6.3.3. Italy In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
11.1.6.3.4. Italy In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.6.3.5. Italy In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.6.4. Spain
11.1.6.4.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.4.2. Spain In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.6.4.3. Spain In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
11.1.6.4.4. Italy In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.6.4.5. Italy In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
11.1.6.5. Rest of Europe
11.1.6.5.1. Market size and projections, 2015 – 2025
11.1.6.5.2. Rest of Europe In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.6.5.3. Rest of Europe In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
11.1.6.5.4. Rest of Europe In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.6.5.5. Rest of Europe In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 12. Asia Pacific In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1. Asia Pacific In Situ Hybridization Market Overview, 2020 & 2027(%)
12.1.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.2. Asia Pacific In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
12.1.3. Asia Pacific In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
12.1.4. Asia Pacific In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
12.1.5. Asia Pacific In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.6. Asia Pacific In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1.6.1. India
12.1.6.1.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.1.2. India In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
12.1.6.1.3. India In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
12.1.6.1.4. India In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
12.1.6.1.5. India In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.6.2. China
12.1.6.2.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.2.2. China In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
12.1.6.2.3. China In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
12.1.6.2.4. China In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
12.1.6.2.5. China In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.6.3. Japan
12.1.6.3.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.3.2. Japan In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
12.1.6.3.3. Japan In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
12.1.6.3.4. Japan In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
12.1.6.3.5. Japan In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.6.4. South Korea
12.1.6.4.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.4.2. South Korea In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
12.1.6.4.3. South Korea In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
12.1.6.4.4. South Korea In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
12.1.6.4.5. South Korea In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.5.2. Rest of Asia Pacific In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
12.1.6.5.3. Rest of Asia Pacific In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
12.1.6.5.4. Rest of Asia Pacific In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
12.1.6.5.5. Rest of Asia Pacific In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 13. Middle East & Africa In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
13.1. Middle East & Africa In Situ Hybridization Market Overview, 2015 - 2027(USD Billion)
13.1.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.2. Middle East & Africa In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
13.1.3. Middle East & Africa In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
13.1.4. Middle East & Africa In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
13.1.5. Middle East & Africa In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
13.1.6. Middle East & Africa In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
13.1.6.1. GCC
13.1.6.1.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.1.2. GCC In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
13.1.6.1.3. GCC In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
13.1.6.1.4. GCC In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
13.1.6.1.5. GCC In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
13.1.6.1.6. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.1.7. South Africa In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
13.1.6.1.8. South Africa In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
13.1.6.1.9. South Africa In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
13.1.6.1.10. South Africa In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
13.1.6.2. Rest of Middle East & Africa
13.1.6.2.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.2.2. Rest of Middle East & Africa In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
13.1.6.2.3. Rest of Middle East & Africa In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
13.1.6.2.4. Rest of Middle East & Africa In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
13.1.6.2.5. Rest of Middle East & Africa In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 14. South America In Situ Hybridization Market Overview, By Countries, 2015 - 2027(USD Billion)
14.1. South America In Situ Hybridization Market Overview, 2015 - 2027(USD Billion)
14.1.1. Market size and projections, 2015 - 2027(USD Billion)
14.1.2. South America In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
14.1.3. South America In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
14.1.4. South America In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
14.1.5. South America In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
14.1.6. South America In Situ Hybridization Market Overview, By Countries, 2015- 2026(USD Billion)
14.1.7. Brazil
14.1.7.1. Market size and projections, 2015 - 2027(USD Billion)
14.1.7.2. Brazil In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
14.1.7.3. Brazil In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
14.1.7.4. Brazil In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
14.1.7.5. Brazil In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
14.1.8. Argentina
14.1.8.1. Market size and projections, 2015 - 2027(USD Billion)
14.1.8.2. Argentina In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
14.1.8.3. Argentina In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
14.1.8.4. Argentina In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
14.1.8.5. Argentina In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
14.1.9. Rest of South America
14.1.9.1. Market size and projections, 2015 – 2027
14.1.9.2. Rest of South America In Situ Hybridization Market Overview, By Product, 2015 - 2027(USD Billion)
14.1.9.3. Rest of South America In Situ Hybridization Market Overview, By Technology, 2015 - 2027(USD Billion)
14.1.9.4. Rest of South America In Situ Hybridization Market Overview, By Application, 2015 - 2027(USD Billion)
14.1.9.5. Rest of South America In Situ Hybridization Market Overview, By End User, 2015 - 2027(USD Billion)
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New product development
Chapter 16. Key Vendor Analysis
16.1. Abbott Laboratories
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Product Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. F. Hoffmann-La Roche Ltd
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Product Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Agilent Technologies
16.4. Abnova Corporation
16.5. BioGenex Laboratories
16.6. Others
Chapter 17. In Situ Hybridization Market Cost Analysis
17.1. Key Raw Materials Analysis
17.1.1. Key Raw Materials
17.1.2. Price Trend of In Situ Hybridization Key Raw Materials
17.1.3. Key Suppliers of Raw Materials
17.1.4. Market Concentration Rate of Raw Materials
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Industrial Chain Analysis
18.2. Upstream Raw Materials Sourcing
18.3. Raw Materials Sources of In Situ Hybridization Major Manufacturers in 2020
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Industry
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global In Situ Hybridization Market share, By Product, 2020 & 2027 (%)
10. Global In Situ Hybridization Market, by Consumables, By Product, 2015 - 2027(USD Billion)
11. Global In Situ Hybridization Market, by Instruments, By Product, 2015 - 2027(USD Billion)
12. Global In Situ Hybridization Market, by Software, By Product, 2015 - 2027(USD Billion)
13. Global In Situ Hybridization Market share, By Technology, 2020 & 2027 (%)
14. Global In Situ Hybridization Market, by FISH, By Technology, 2015 - 2027(USD Billion)
15. Global In Situ Hybridization Market, by CISH, By Technology, 2015 - 2027(USD Billion)
16. Global In Situ Hybridization Market share, By Application, 2020 & 2027 (%)
17. Global In Situ Hybridization Market, by Cancer Diagnostics, By Application, 2015 - 2027(USD Billion)
18. Global In Situ Hybridization Market, by Cytology, By Application, 2015 - 2027(USD Billion)
19. Global In Situ Hybridization Market, by Infectious Disease Diagnostics, By Application, 2015 - 2027(USD Billion)
20. Global In Situ Hybridization Market, by Neuroscience, By Application, 2015 - 2027(USD Billion)
21. Global In Situ Hybridization Market, by Immunology, By Application, 2015 - 2027(USD Billion)
22. Global In Situ Hybridization Market share, By End User, 2020 & 2027 (%)
23. Global In Situ Hybridization Market, by Hospitals & Diagnostic Laboratories, By End User, 2015 - 2027(USD Billion)
24. Global In Situ Hybridization Market, by Academic & Research Institutes, By End User, 2015 - 2027(USD Billion)
25. Global In Situ Hybridization Market, by Pharmaceutical & Biotechnology Companies, By End User, 2015 - 2027(USD Billion)
26. Global In Situ Hybridization Market, by Pharmaceutical & Biotechnology Companies, By End User, 2015 - 2027(USD Billion)
27. Global In Situ Hybridization Market share, by region, 2020 & 2027 (%)
28. North America In Situ Hybridization Market, 2020 - 2027(USD Billion)
29. North America In Situ Hybridization Market share, by Countries, 2020 & 2027 (%)
30. U.S. In Situ Hybridization Market, 2020 - 2027(USD Billion)
31. Canada In Situ Hybridization Market, 2020 - 2027(USD Billion)
32. Europe In Situ Hybridization Market, 2020 - 2027(USD Billion)
33. Europe In Situ Hybridization Market share, by Countries, 2020 & 2027 (%)
34. Spain In Situ Hybridization Market, 2020 - 2027(USD Billion)
35. UK In Situ Hybridization Market, 2020 - 2027(USD Billion)
36. Italy In Situ Hybridization Market, 2020 - 2027(USD Billion)
37. Germany In Situ Hybridization Market, 2020 - 2027(USD Billion)
38. France In Situ Hybridization Market, 2020 - 2027(USD Billion)
39. Rest of Europe In Situ Hybridization Market, 2020 - 2027(USD Billion)
40. Asia-Pacific In Situ Hybridization Market, 2020 - 2027(USD Billion)
41. Asia-Pacific In Situ Hybridization Market share, by Countries, 2020 & 2027 (%)
42. China In Situ Hybridization Market, 2020 - 2027(USD Billion)
43. India In Situ Hybridization Market, 2020 - 2027(USD Billion)
44. Australia In Situ Hybridization Market, 2020 - 2027(USD Billion)
45. Japan In Situ Hybridization Market, 2020 - 2027(USD Billion)
46. Rest of Asia-Pacific In Situ Hybridization Market, 2020 - 2027(USD Billion)
47. Middle East & Africa In Situ Hybridization Market, 2020 - 2027(USD Billion)
48. Middle East & Africa In Situ Hybridization Market share, by Countries, 2020 & 2027 (%)
49. GCC In Situ Hybridization Market, 2020 - 2027(USD Billion)
50. South Africa In Situ Hybridization Market, 2020 - 2027(USD Billion)
51. Rest Of Middle East & Africa In Situ Hybridization Market, 2020 - 2027(USD Billion)
52. South America In Situ Hybridization Market, 2020 - 2027(USD Billion)
53. Brazil In Situ Hybridization Market, 2020 - 2027(USD Billion)
54. Mexico In Situ Hybridization Market, 2020 - 2027(USD Billion)
55. Argentina In Situ Hybridization Market, 2020 - 2027(USD Billion)
56. Rest of South America In Situ Hybridization Market, 2020 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global In Situ Hybridization Market, 2015-2027(USD Billion)
4. Global In Situ Hybridization Market requirement, by country, 2015-2027,(USD Billion)
5. North America In Situ Hybridization Market, By Product, 2015-2027(USD Billion)
6. North America In Situ Hybridization Market, By Technology, 2015-2027(USD Billion)
7. North America In Situ Hybridization Market, By Application, 2015-2027(USD Billion)
8. North America In Situ Hybridization Market, By End User, 2015-2027(USD Billion)
9. Europe In Situ Hybridization Market, By Product, 2015-2027(USD Billion)
10. Europe In Situ Hybridization Market, By Technology, 2015-2027(USD Billion)
11. Europe In Situ Hybridization Market, By Application, 2015-2027(USD Billion)
12. Europe In Situ Hybridization Market, By End User, 2015-2027(USD Billion)
13. Asia Pacific In Situ Hybridization Market, By Product, 2015-2027(USD Billion)
14. Asia Pacific In Situ Hybridization Market, By Technology, 2015-2027(USD Billion)
15. Asia Pacific In Situ Hybridization Market, By Application, 2015-2027(USD Billion)
16. Asia Pacific In Situ Hybridization Market, By End User, 2015-2027(USD Billion)
17. Middle East & Africa In Situ Hybridization Market, By Product, 2015-2027(USD Billion)
18. Middle East & Africa In Situ Hybridization Market, By Technology, 2015-2027(USD Billion)
19. Middle East & Africa In Situ Hybridization Market, By Application, 2015-2027(USD Billion)
20. Middle East & Africa In Situ Hybridization Market, By End User, 2015-2027(USD Billion)
21. South America In Situ Hybridization Market, By Product, 2015-2027(USD Billion)
22. South America In Situ Hybridization Market, By Technology, 2015-2027(USD Billion)
23. South America In Situ Hybridization Market, By Application, 2015-2027(USD Billion)
24. South America In Situ Hybridization Market, By End User, 2015-2027(USD Billion)
25. Global In Situ Hybridization Market, Company Market Share, 2020 (%)
26. Abbott Laboratories: Product Benchmarking
27. Abbott Laboratories: Financial Performance
28. F. Hoffmann-La Roche Ltd: Product Benchmarking
29. F. Hoffmann-La Roche Ltd: Financial Performance
30. Agilent Technologies: Product Benchmarking
31. Agilent Technologies: Financial Performance
32. Abnova Corporation: Product Benchmarking
33. Abnova Corporation: Financial Performance
34. BioGenex Laboratories: Product Benchmarking
35. BioGenex Laboratories: Financial Performance

The Leading Key Players in In Situ Hybridization Market

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Agilent Technologies
Abnova Corporation
BioGenex Laboratories
Bio-Techne Corporation
Biocare Medical
Bio SB